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The differential attrition of persons from comparison groups severely restricts the
inferences that can be made from results of evaluative research. This problem is
particularly troublesome in the evaluation of medical technologies, such as coronary
artery bypass graft surgery, since a substantial percentage of medical or control patients
cross over to the surgical group. A procedure using worst case assumptions is developed
that allows researchers to estimate the maximum effect of differential attrition, and
therefore enhance the quality of their inferences. The article first illustrates theprocedure,
then concludes with a discussion of the generality of the estimation procedure to other
instances in which differential attrition is a problem, and points out the limitations of the
approach.
A mong the various ways that research designs are comprised,perhaps the most troublesome is the differential attrition of
subjects from comparison groups during the actual conduct of an
evaluation or experiment (Cook and Campbell, 1979). For example,
Boeckmann’s reanalysis (1981) of the New Jersey negative income tax
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experiment (Watts and Rees, 1977) suggests that differential attrition
from the experimental and control groups of both black and Spanish-
speaking minorities could account for differences otherwise attributable
to the intervention. Likewise, Wortman (1978) has argued that the
process of differential attrition was a plausible explanation of the
negative effects found in McCord’s (1978) 30-year follow-up of the
relationship of counseling to subsequent delinquency in a randomized
controlled trial.
As a result of this differential attrition process, a well-conceived
randomized experimental design may drift toward a quasi-experimental
design model with all of its inferential limitations (see, for example,
Special Report, 1982). Despite the creative application of statistical
procedures to adjust for the resulting nonequivalence between groups
(Kenny, 1975; Magidson, 1977; Reichardt, 1979), there is no satisfactory
statistical solution to the lack of adherence to the original design
protocol.
The most common recommendation of methodologists is to analyze
the data from randomized experiments according to the original
assignment (Riecken and Boruch, 1974) or &dquo;intention to treat&dquo; (Peto et
al., 1976). This approach is a tradeoff that preserves the design at the
expense of a biased estimate of the treatment effect.
THE PROBLEM OF CROSSOVERS
In the assessment of medical technologies, researchers will often
confront situations in which specific techniques are preferred by
patients due to their association with secondary outcomes that are
intrinsically desirable. In instances such as these, it will be particularly
difficult to maintain the design protocol. This precise situation confronts
researchers interested in the evaluation of the potential benefits of
coronary artery bypass graft surgery (CABGS) for patients with
coronary heart disease (Wortman, 1981).
Given the consistent finding that angina is relieved in patients
receiving surgery (Special Report, 1981), it is ethically problematic to
withhold a potential benefit from the medical group. Accordingly, any
efforts to compare survival rate between patients who are operated on
and those adhering to a medical regimen are greatly complicated by the
versions of this paper. Requests for reprints should be sent to Dr. William H. Yeaton,
Center for Research on the Utilization of Scientific Knowledge, University of Michigan,
Box 1248, Ann Arbor, Michigan, 48106.
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fact that substantial percentages of medical patients cross over to the
group of patients who receive surgery. Furthermore, the migration is
unidirectional since it is not possible for patients to cross over from the
surgical to the medical groups once they have received surgery.
In a synthesis of results from 25 controlled trials of CABGS
(Wortman and Yeaton, 1983), the crossover rates from the medical to
the surgical group were found to be quite sizeable, ranging up to 45.0%
in randomized controlled trials, with a mean rate of 21%. Compounding
this problem is the systematic nature of the attrition. It is typically those
medical patients with the worst prognosis, that is, those with the most
severe angina and imminent danger of heart attacks who become
crossovers (Murphy, Hultgren, Detre, Thomsen, and Takaro, 1977:
1470). As these researchers have noted:
Medical nonadhcrers are frequently assumed to be treatment failures. Although
this result was true in approximately 54 per cent of our patients (unstable angina,
19 per cent, and progressive angina, 35 per cent), patient or physician preference
prevailed in some cases.
ESTIMATING THE EFFECT OF CROSSOVERS
Any inferences that are made from controlled trials of CABGS must
weigh the extent to which patients in the medical group have crossed
over to receive surgery. Clearly, the effect of the loss of the most ill
patients from the medical group is to raise the survival rate in the
medical group. Whether crossovers are dropped from the study or
included, as most evaluation methodologists recommend, the extent of
the increase is not readily apparent (Wortman, 1981).
In fact, the most common biostatistical research practice is to
consider crossovers as an endpoint, that is, as no longer in the study, at
the time they receive surgery. This would bring the medical group
survival rate closer to that for the surgical group, if one assumes that
surgery is beneficial, an assumption consistent with the data. Con-
sequently, the crossover problem will underestimate any potential
benefit due to surgery. If one follows the recommendation to include
crossovers in their originally assigned group, then the effectiveness of
surgery will also be underestimated (again assuming it is beneficial).
Neither method then can overcome the effects of differential attrition
and treatment diffusion to produce an unbiased estimate of effect.
The worst case approach uses a general strategy of determining the
maximum degree of influence attributable to a particular factor and
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thus the factor’s likelihood of contributing to the difference obtained. In
this way it resembles the sensitivity analysis used by economists in
cost-effectiveness and cost-benefit analyses (Weinstein and Stason,
1982) to ascertain the consistency of conclusions under various condi-
tions such as extreme and intermediate values of the discount rate in
determining present costs. If conclusions are preserved under worst case
assumptions, one can place considerable confidence in the validity of the
results. If conclusions are contingent upon the values assumed, one can
judge &dquo;up front&dquo; the plausibility of the value that is needed to maintain
consistent conclusions.
Though the very nature of crossovers makes it impossible to
determine exactly the effect of such attrition on survival rate, it is
possible to estimate the maximum influence that crossovers would have
on the mean survival rate of the medical group. By calculating this
maximum influence attributable to crossovers, researchers would be in
a greatly improved position for defending inferences about differences
between medical and surgical groups. Since this procedure is likely to
overadjust for attrition, it could provide convergent evidence if it agrees
with the more traditional estimates, in their direction if not their
magnitude.
This estimation procedure necessitates some very specific assump-
tions, however. We will assume that only those patients in the medical
group with the worst prognosis cross over to receive surgery, and that
these patients are considered as an endpoint at the time they cross over.
With regard to the distribution of survival rates of medical patients,
this assumption implies that the tail of the distribution is truncated at
precisely the point that will eliminate the exact percentage of patients
who cross over. This means that the area under the distribution curve
that is eliminated will coincide with the percentage of patients who cross
over. We further assume a distribution of composite measures of health
status that reflects the probability of survival for medical patients after
the time patients in the surgical group have received CABGS. We also
hypothesize that the measure is standardized normal (so that the mean
equals zero and standard deviation equals one), allowing us to use
standard formulae to calculate the mean of the truncated distribution.
Though truncated, standard normal distributions are also employed by
economists (Stromsdorfer and Farkas, 1980), they are commonly used
to correct statistically for attrition bias in ANOVA and regression
models (Hansman and Wise, 1979) rather than to form a basis for a
worst case solution.
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Formally, if f is a density function defined by
where x assumes any real number value, then for any given percentage p
of crossovers, the area under the normal curve yielding this percentage p
can be found by integrating the normal curve density function from
minus infinity to that point z on the x-axis which yields p as the result of
the integration:
The mean of interest (the mean of the truncated distribution) will be:
Given various crossover rates p, one can use a table of standard
normal deviates to determine the corresponding z-value on the abscissa.
These two constants can then be substituted into the above result for the
mean of the truncated distribution to ascertain the magnitude of shift of
the mean.
Examples
For purposes of illustration, several p values and the corresponding
means of interest are displayed below. When plotted, the relationship
appears to be essentially linear.
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Thus, the crossover rate of 21 % (when p = .21 ) found in the authors’
synthesis of the results of controlled trials of CABGS (Wortman and
Yeaton, 1983 would be associated with a mean shift of .36 (a 36%
increase in the standardized mean value), the maximum change
attributable solely to crossovers.
In some instances it will not be necessary to translate shifts calculated
in standardized units to their equivalents in unstandardized terms.
Measures of effect size (Glass, McGaw, and Smith, 1981) are calculated
by dividing mean differences by an appropriate standard deviation and
thus are directly comparable to results generated from mean shifts in the
standard normal distribution. For example, given an effect size of .50
and a crossover rate of 21 %, one can determine the maximum effect of
crossover by simply adding .36, the mean shift, to .50, to adjust for the
underestimated outcome measure. By comparing this adjusted value to
the original value, one can estimate the extent to which a difference
between groups is likely to be due to crossovers.
In other cases there will be no immediately obvious standard
deviation value by which one can standardize results, but reasonable
estimates may be available. For example, in the medical research cited
above, survival rates were assumed to be reflected in the distribution of
composite measures of health status, and these measures might be used
to produce a standard deviation. Another measure of variability might
be the standard deviation of the survival means of other similar studies.
For example, given a medical group mean survival percent of 65 and a
standard deviation of 10 found from a composite index of health status,
the maximum effect of a 21 % crossover rate would be 3.6 (.36 times 10).
Therefore, the survival rate would be increased to 68.6 as a result of
crossovers.
In practice, means and standard deviations are available after
crossovers have occurred, and researchers will be interested in deter-
mining the adjusted mean before the effect of crossovers. In this case,
one simply subtracts the product of the percent shift and the standard
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deviation from the given mean. As an illustration, again assume a
medical group mean survival percent of 65 and a standard deviation of
10 percent, values determined after crossovers. The adjusted mean
would be 61.4 (65 -.36(10)), thus allowing the researcher to conclude
that the difference between medical and surgical groups would be
underestimated by a maximum of 3.6 percentage points as a result of
crossovers, assuming that the mean in the surgical group is greater than
the mean in the medical group. While in the case of attrition due to
crossovers it is obvious that an adjustment must be made in the control
group measure, the practice is consistent with the identification of
distortion in research that uses historical (Sachs, Chalmers, and Smith,
1982) and other nonrandomized controls (Meier, 1978).
GENERAL COMMENTS
These findings suggest that high crossover rates can substantially
increase the mean of the distribution of the control group of medical
patients in which crossovers have been eliminated. Consequently, the
benefit attributable to surgery would be substantially underestimated in
controlled trials of CABGS. While from a statistical point of view mean
shifts between 20% and 50% would be considered between small and
medium effect sizes (Cohen, 1977), innovative surgeries typically
produce modest benefits (Gilbert, McPeek, and Mosteller, 1977) that
assume importance through their implementation with large groups of
patients. For example, the evidence from randomized controlled trials
suggests a benefit of CABGS of less than 5% (Wortman and Yeaton,
1983). Fortunately, the ability to detect these modest benefits is
enhanced considerably by the above estimation technique, since the
degree to which crossovers may alter a group mean and thus underesti-
mate differences between groups can be determined easily.
Of course, the relationship between the rate of crossovers and the
shift in mean survival rate found in actual reports of CABGS will not
follow the idealized relationship described above. Distributions may
only approximate the normal, and variances will change as a function of
the range of diagnostic severity of patients in the medical group. To the
degree that the distribution is negatively skewed or the variance is large,
the shift in the mean will increase. Also, not all medical patients will
cross over at the same point in time, as we have assumed in our
calculations.
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When there is a high incidence of crossovers early in the follow-up
period of a controlled trial, the degree of bias attributable to crossovers
will be maximal. The longer the delay period before patients begin to
cross over from the medical group, the closer one approaches the case of
an intact control group. Furthermore, we have assumed that only the
worst medical patients cross over, an assumption not likely to be true in
actual practice. However, the closer the mix of crossovers approximates
the case in which only the worst medical patients cross over, the closer
the mean shift will approximate the maximum shift shown in this report.
The problem of crossovers in the assessment of effectiveness of
CABGS is illustrative of the differential attrition process that plagues
evaluation research. The &dquo;solution&dquo; presented here is applicable to those
instances in which the differential attrition process selects subjects or
patients in the same manner as they were selected in this report.
Specifically, if a differentially attrited subgroup of persons is homo-
geneous on some measure(s) of status (such as health in this report,
occupation in the McCord (1978) study, and ethnicity in the Watts and
Rees (1977) volume) that correlates with the outcome variable in
question, then the findings of this report are relevant. Obviously, the
degree of direct relevance will depend on the match of the groups
resulting from the differential attrition process to the pertinent assump-
tions upon which our estimates are based: attrition of only worst case
persons from one of the comparison groups and the shape of the
relevant distributions. Other potentially important factors such as the
strength of correlation between the status and the outcome measures
may compensate for departures from worst case assumptions, however.
While the emphasis of this report has been on the accurate
interpretation of research results in studies plagued by differential
attrition, the findings may also be used in planning studies. Briefly, if
one is armed with knowledge from past studies with regard to the
expected rate of crossovers, precise estimates can be made of the degree
to which the magnitude of difference between groups is likely to be
altered. Accordingly, sample sizes can be either increased or decreased
to reflect smaller or larger differences between groups, thus enhancing
the power of experiments or diminishing their expected costs.
Despite the shortcomings associated with idealized data, the relation-
ship between crossover rates and survival presented in this report will
allow researchers to estimate more accurately the potential influence of
crossovers, and thus to improve the quality of their inferences. Given the
uncertainties in interpreting the results from flawed research studies, it is
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important that investigators acknowledge the potential bias caused by
such &dquo;threats to validity&dquo; (Campbell and Stanley, 1966). These problems
are much more common in the applied field studies characteristic of
program evaluation and medical technology assessment. Worst case
assumptions can provide a bound for a treatment’s impact and indicate
the extent to which the estimate of effect is sensitive to bias.
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